Seres Therapeutics, Inc. · NASDAQ:MCRB

Shaff Eric D. sold 287 Seres Therapeutics, Inc. shares (Form 4)

Traded Nov 15 to Nov 16, 2026 · Filed Nov 17, 2026

From Nov 15 to Nov 16, 2026, Shaff Eric D. (Director) sold 287 Seres Therapeutics, Inc. shares at US$1.38 for US$396 under a trading plan, leaving 12,936 shares. Filed Nov 17, 2026 (Form 4).

Sold
287 shares
Price
US$1.38
Value
US$396
Holding after
12,936 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 15, 2026Common StockOption exercise72413,223Direct
Nov 16, 2026Common StockSale287US$1.3812,936Direct

Source

Download original · View original at SEC

Related